DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Positive impactResults

Sudeep Pharma Q2 FY27 results: Net profit rises nearly 13% to ₹52 crore, revenue up 21%

CNBC-TV18 1 hr ago·28 Oct 2026, 2:16 pm

Sudeep Pharma reported a 12.7% rise in Q2 net profit to ₹52 crore, with revenue increasing 20.9% to ₹197 crore and EBITDA growing 32% to ₹73.2 crore.

Affected stocks

Bullish1 stock

Sudeep Pharma

SUDEEPPHRM Bullish

₹1,119.00

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Sudeep Pharma (SUDEEPPHRM).
Category: Results.
AI reads the tone as positive (potentially bullish) for the stock.

Why it matters

A routine update for Sudeep Pharma. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at CNBC-TV18.